Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

BCTX BriaCell Therapeutics Corporation

1,42

0,04 (2,90%)

18 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

News Brief: BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) a clinical-stage immunotherapy company driven to fight cancer and improve patients’ lives, announced that it has received approval...

To read the full story on AllPennyStocks.com, click here.

BriaCell Therapeutics (NASDAQ:BCTX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more BriaCell Therapeutics Charts.

BriaCell Therapeutics (NASDAQ:BCTX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more BriaCell Therapeutics Charts.

News BriaCell Therapeutics Corporation

BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
Freitag 17 Mai 2024 (2 Tage vor) • GlobeNewswire Inc.

BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering
Mittwoch 15 Mai 2024 (4 Tage vor) • GlobeNewswire Inc.

BriaCell Announces Oral and Poster Presentations at ASCO 2024
Mittwoch 24 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer
Mittwoch 10 April 2024 (1 Monat vor) • GlobeNewswire Inc.

BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR
Dienstag 9 April 2024 (1 Monat vor) • GlobeNewswire Inc.

BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies
Donnerstag 7 März 2024 (2 Monate vor) • GlobeNewswire Inc.

BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference
Mittwoch 6 März 2024 (2 Monate vor) • GlobeNewswire Inc.

BriaCell Provides Update on Alleged Illegal Trading of Public Securities
Dienstag 27 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case
Mittwoch 7 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing
Dienstag 6 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Donnerstag 1 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 31 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere BriaCell Therapeutics Corporation News-Artikel

Spirits Time (PK)

Matthews Emerging Market...

Vontobel Financial Produ...

Stanley Black & Decker

Republic of France 0.500...

Transfield Services

Vontobel Financial Produ...

Allianzim US Equity 6 Mo...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen